NCM·Healthcare·$82M·#98 / 520 in Healthcare
CSBR Champions Oncology, Inc.
64SOLID
CATEGORY BREAKDOWN
GROWTH22
QUALITY63
STABILITY67
VALUATION98
GOVERNANCE94
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+13.5%
22
> 50% strong
Gross Margin
Revenue retained after direct costs
50.1%
70
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
161.9%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.4x
98
< 3x strong
Rule of 40
Growth rate plus operating margin
22
53
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
26.7%
95
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.3%
92
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CSBR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CSBR's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.